Status:
RECRUITING
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
Lead Sponsor:
Alcon Research
Conditions:
Aphakia
Presbyopia
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. T...
Detailed Description
Subjects will attend 9 scheduled study visits for a total individual duration of participation of approximately 7 months. Both eyes will undergo cataract surgery. The second eye surgery will occur wit...
Eligibility Criteria
Inclusion
- Key
- Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification);
- Subject must be able to understand and sign an approved informed consent form;
- Subject is willing to complete all the required study visits for the duration of the study;
- Other protocol-defined inclusion criteria may apply.
- Key
Exclusion
- Ocular conditions as specified in the protocol;
- Subjects who desire monovision correction;
- Previous intraocular or corneal surgery;
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
October 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07161635
Start Date
October 14 2025
End Date
October 1 2026
Last Update
October 21 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Wolstan & Goldberg Eye Associates
Torrance, California, United States, 90505
2
Moyes Eye Center
Kansas City, Missouri, United States, 64154
3
Carolina Eyecare Physicians LLC
Mt. Pleasant, South Carolina, United States, 29464
4
Houston Eye Associates
Houston, Texas, United States, 77008